NovaBay Pharmaceuticals, Inc.

AMEX (USD): NovaBay Pharmaceuticals, Inc. (NBY)

Last Price

0.66

Today's Change

+0.163 (32.79%)

Day's Change

0.654 - 0.94

Trading Volume

97,773,402

Overview

Market Cap

3 Million

Shares Outstanding

4 Million

Avg Volume

275,280

Avg Price (50 Days)

0.86

Avg Price (200 Days)

3.77

PE Ratio

-0.01

EPS

-76.04

Earnings Announcement

07-Nov-2024

Previous Close

0.50

Open

0.87

Day's Range

0.654 - 0.9395

Year Range

0.36 - 17.85

Trading Volume

97,805,780

Price Change Highlight

1 Day Change

32.50%

5 Day Change

32.05%

1 Month Change

18.24%

3 Month Change

-71.05%

6 Month Change

-86.53%

Ytd Change

-90.31%

1 Year Change

-95.73%

3 Year Change

-99.91%

5 Year Change

-99.92%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment